Demographic and clinical variables are shown for the cardiac sarcoidosis cohort
| Demographics and clinical variable . | Patients . |
|---|---|
| Male | 152/235 (64.7%) |
| Age (n = 231) | 55.6 ± 11.1 (range 22–82) |
| Status alive | 193/209 (92.3%) |
| NYHA Class I | 89/203 (43.8%) |
| Class II | 68/203 (33.5%) |
| Class III | 42/203 (20.7%) |
| Class IV | 4/203 (2.0%) |
| Secondary prevention | 88/235 (37.5%) |
| Syncope | 68/235 (28.9%) |
| Family history of sarcoid | 14/187 (7.5%) |
| LVEF (%) (n = 233) | 45.0 ± 15.7 (range 5–74) |
| Abnormal cardiac MRI | 99/115 (86.1%) |
| Abnormal cardiac biopsy | 41/58 (70.7%) |
| Demographics and clinical variable . | Patients . |
|---|---|
| Male | 152/235 (64.7%) |
| Age (n = 231) | 55.6 ± 11.1 (range 22–82) |
| Status alive | 193/209 (92.3%) |
| NYHA Class I | 89/203 (43.8%) |
| Class II | 68/203 (33.5%) |
| Class III | 42/203 (20.7%) |
| Class IV | 4/203 (2.0%) |
| Secondary prevention | 88/235 (37.5%) |
| Syncope | 68/235 (28.9%) |
| Family history of sarcoid | 14/187 (7.5%) |
| LVEF (%) (n = 233) | 45.0 ± 15.7 (range 5–74) |
| Abnormal cardiac MRI | 99/115 (86.1%) |
| Abnormal cardiac biopsy | 41/58 (70.7%) |
Demographic and clinical variables are shown for the cardiac sarcoidosis cohort
| Demographics and clinical variable . | Patients . |
|---|---|
| Male | 152/235 (64.7%) |
| Age (n = 231) | 55.6 ± 11.1 (range 22–82) |
| Status alive | 193/209 (92.3%) |
| NYHA Class I | 89/203 (43.8%) |
| Class II | 68/203 (33.5%) |
| Class III | 42/203 (20.7%) |
| Class IV | 4/203 (2.0%) |
| Secondary prevention | 88/235 (37.5%) |
| Syncope | 68/235 (28.9%) |
| Family history of sarcoid | 14/187 (7.5%) |
| LVEF (%) (n = 233) | 45.0 ± 15.7 (range 5–74) |
| Abnormal cardiac MRI | 99/115 (86.1%) |
| Abnormal cardiac biopsy | 41/58 (70.7%) |
| Demographics and clinical variable . | Patients . |
|---|---|
| Male | 152/235 (64.7%) |
| Age (n = 231) | 55.6 ± 11.1 (range 22–82) |
| Status alive | 193/209 (92.3%) |
| NYHA Class I | 89/203 (43.8%) |
| Class II | 68/203 (33.5%) |
| Class III | 42/203 (20.7%) |
| Class IV | 4/203 (2.0%) |
| Secondary prevention | 88/235 (37.5%) |
| Syncope | 68/235 (28.9%) |
| Family history of sarcoid | 14/187 (7.5%) |
| LVEF (%) (n = 233) | 45.0 ± 15.7 (range 5–74) |
| Abnormal cardiac MRI | 99/115 (86.1%) |
| Abnormal cardiac biopsy | 41/58 (70.7%) |
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
